AMERISAFE (AMSF)
(Delayed Data from NSDQ)
$46.37 USD
-0.06 (-0.13%)
Updated May 17, 2024 04:00 PM ET
After-Market: $46.38 +0.01 (0.02%) 6:20 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$46.37 USD
-0.06 (-0.13%)
Updated May 17, 2024 04:00 PM ET
After-Market: $46.38 +0.01 (0.02%) 6:20 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
Zacks News
Why Hold Strategy is Apt for Arthur J. Gallagher (AJG) Now
by Zacks Equity Research
Arthur J. Gallagher (AJG) is poise to grow on sustained solid performance at its Brokerage and Risk Management segments.
Why Unum Group (UNM) is an Attractive Investment Option Now
by Zacks Equity Research
Unum Group (UNM) is poised to grow in the long haul on the back of its operational excellence and solid fundamentals.
Accident and Health Insurers Near-Term Prospects Gloomy
by Tanuka De
Accident and Health Insurance industry is likely to face pricing pressure. Also, higher spending on technological advancements is expected to result in higher expense ratios.
What's in Store for CME Group (CME) This Earnings Season?
by Zacks Equity Research
CME Group's (CME) second-quarter results are likely to be driven by its strong market position and varied derivative product lines.
Amerisafe (AMSF) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Amerisafe (AMSF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in Store for Discover Financial (DFS) Q2 Earnings?
by Zacks Equity Research
Discover Financial's (DFS) Q2 results are likely to be strengthened by higher revenues and card sales.
Why the Earnings Surprise Streak Could Continue for Amerisafe (AMSF)
by Zacks Equity Research
Amerisafe (AMSF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Moving Average Crossover Alert: Amerisafe
by Zacks Equity Research
Amerisafe, Inc. (AMSF) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Amerisafe Benefits from Specialty in High-Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) niche in providing workers' compensation insurance in high-hazard risk industries, coupled with balance sheet strength and appropriate enterprise risk management aids growth.
Why Is Amerisafe (AMSF) Down 0.4% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Torchmark (TMK) Poised to Grow on Strong Segmental Results
by Zacks Equity Research
Torchmark (TMK) is well positioned, given its superior performance at Global Life, Liberty National and American Income as well as strong capital management.
Aflac (AFL) Hits New 52-Week High: Is Further Upside Left?
by Zacks Equity Research
Strong operating performance in both U.S and Japan businesses is expected to continue the Aflac's (AFL) stock rally.
Amerisafe (AMSF) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Amerisafe (AMSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Amerisafe (AMSF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Amerisafe (AMSF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accident and Health Insurance Near-Term Prospects Bright
by Tanuka De
Increased underwriting exposure, sustained decrease in claims frequency rates, and conservative reserve levels should drive Accident and Health Insurance industry's performance.
Will Aflac (AFL) Retain Positive Earnings Surprise in Q1?
by Zacks Equity Research
Aflac (AFL) Q1 earnings to gain from US segment's higher contribution, partly offset by subdued results from Japan unit.
Is a Beat in the Cards for Synchrony Financial Q1 Earnings?
by Zacks Equity Research
Synchrony Financial's (SYF) first-quarter earnings are likely to grow on the back of higher purchase volume and CareCredit platform.
Can Amerisafe (AMSF) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Amerisafe (AMSF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is Amerisafe (AMSF) Down 5.9% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amerisafe (AMSF) Q4 Earnings Beat Estimates on Lower Expenses
by Zacks Equity Research
Amerisafe's (AMSF) Q4 earnings beat was driven by increase in net investment income and decline in total expenses.
Amerisafe (AMSF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Amerisafe (AMSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amerisafe Set to Grow on its Niche in High-Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) wide presence in high-hazard risk insurance, a strong capital position and disciplined underwriting should drive growth.
New Strong Buy Stocks for December 19th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Aflac's (AFL) Minority Stake Being Eyed by Japan Post
by Zacks Equity Research
Japan Post seems interested in buying a minority stake in Aflac (AFL) to expand its overseas business.
Near-Term Outlook for Accident and Health Insurance Industry
by Zacks Equity Research
Growth in underwriting exposure, a continued decline in claims frequency rates, and conservative reserve levels should drive Accident and Health Insurance industry's performance.